|
Greystone Pharmaceuticals |
|
|
16261 Bass Road Suite 202
Fort Myers, FL 33908 USA
phone:(239) 432-2780
fax:(239) 432-2782
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.greystonepharmaceuticals.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Wound care technologies to improve quality of life and healthcare outcomes for patients who suffer from chronic wounds.
|
|
| Management |
| Gregory P. Pilant, Chairman and CEO; Martin Doyle, President and COO; Kevin R. Douglas, CFO; Dr. Kel Cohen, Chief Medical Officer; Catherine Harley, Vice President of Clinical Business Development; Erik Valk, Managing Director, Dermagenics Europe; Barry Willemsteijn, Director of Sales & Marketing, Dermagenics Europe |
| |
|
|
| |
|
| Keywords |
| diabetes, ulcer, decubitis ulcer, advamed |
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members